Circulating Microrna-1A is a Biomarker of Graves' Disease Patients with Atrial Fibrillation.

Fang Wang,Sheng-jie Zhang,Xuan Yao,Dong-mei Tian,Ke-qin Zhang,Dun-min She,Fei-fan Guo,Qi-wei Zhai,Hao Ying,Ying Xue
DOI: https://doi.org/10.1007/s12020-017-1331-4
2017-01-01
Endocrine
Abstract:It has been increasingly suggested that specific microRNAs expression profiles in the circulation and atrial tissue are associated with the susceptibility to atrial fibrillation. Nonetheless, the role of circulating microRNAs in Graves’ disease patients with atrial fibrillation has not yet been well described. The objective of the study was to identify the role of circulating microRNAs as specific biomarkers for the diagnosis of Graves’ disease with atrial fibrillation.
What problem does this paper attempt to address?